{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T09:01:43Z","timestamp":1769936503861,"version":"3.49.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T00:00:00Z","timestamp":1570752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P50NS048843"],"award-info":[{"award-number":["P50NS048843"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01071","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T04:38:31Z","timestamp":1570768711000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries"],"prefix":"10.3389","volume":"10","author":[{"given":"Cecilia","family":"Higgs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Hilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libby","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Martens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Marini-Bettolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikoletta","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotana","family":"Alsaggaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard T.","family":"Moxley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahinaz M.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol Clin"},{"key":"B2","first-page":"385","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member","volume":"69","author":"Brook","year":"1992","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1126\/science.1546326","article-title":"An unstable triplet repeat in a gene related to myotonic muscular dystrophy","volume":"255","author":"Fu","year":"1992","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.1546325","article-title":"Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene","volume":"255","author":"Mahadevan","year":"1992","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/570","article-title":"Genetic mapping of a second myotonic dystrophy locus","volume":"19","author":"Ranum","year":"1998","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fneur.2018.00303","article-title":"Core clinical phenotypes in myotonic dystrophies","volume":"9","author":"Wenninger","year":"2018","journal-title":"Front Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.3233\/JND-150088","article-title":"Myotonic dystrophy type 2: an update on clinical aspects, genetic and pathomolecular mechanism","volume":"2","author":"Meola","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"B9","unstructured":"Myotonic dystrophy type 2\n            DaltonJC\n            RanumLPW\n            DayJW\n          \n            AdamMP\n            ArdingerHH\n            PagonRA\n            WallaceSE\n            BeanLJH\n            StephensK\n            AmemiyaA\n          Seattle, WAUniversity of WashingtonGeneReviews2006"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/acn3.50856","article-title":"Benign tumors in myotonic dystrophy type I target disease-related cancer sites","volume":"6","author":"Alsaggaf","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/mus.26194","article-title":"Cancer phenotype in myotonic dystrophy patients: results from a meta-analysis","volume":"58","author":"Emparanza","year":"2018","journal-title":"Muscle Nerve"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ijc.31143","article-title":"Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink","volume":"142","author":"Wang","year":"2018","journal-title":"Int J Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1001\/jama.2011.1796","article-title":"Cancer risk among patients with myotonic muscular dystrophy","volume":"306","author":"Gadalla","year":"2011","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0000000000003124","article-title":"Cancer risk in DM1 is sex-related and linked to miRNA-200\/141 downregulation","volume":"87","author":"Fernandez-Torron","year":"2016","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1016\/j.lpm.2013.01.052","article-title":"[Increasing risk of tumors in myotonic dystrophy type 1]","volume":"42","author":"Mohamed","year":"2013","journal-title":"Presse Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"pky052","DOI":"10.1093\/jncics\/pky052","article-title":"Cancer risk in myotonic dystrophy type i: evidence of a role for disease severity","volume":"2","author":"Alsaggaf","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s00415-015-8006-y","article-title":"Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors","volume":"263","author":"Bianchi","year":"2016","journal-title":"J Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/mus.25736","article-title":"Benign and malignant tumors in the UK myotonic dystrophy patient registry","volume":"57","author":"Alsaggaf","year":"2018","journal-title":"Muscle Nerve"},{"key":"B19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00415-017-8483-2","article-title":"The UK myotonic dystrophy patient registry: facilitating and accelerating clinical research","volume":"264","author":"Wood","year":"2017","journal-title":"J Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cct.2011.11.016","article-title":"If you build a rare disease registry, will they enroll and will they use it?","volume":"33","author":"Hilbert","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/ene.13763","article-title":"Survival patterns and cancer determinants in families with myotonic dystrophy type I","volume":"25","author":"Best","year":"2018","journal-title":"Eur J Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ene.13276","article-title":"Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy","volume":"24","author":"Gadalla","year":"2017","journal-title":"Eur J Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00415-012-6476-8","article-title":"Correlates of tumor development in patients with myotonic dystrophy","volume":"259","author":"Das","year":"2012","journal-title":"J Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1542\/peds.111.1.110","article-title":"Age at menarche and racial comparisons in US girls","volume":"111","author":"Chumlea","year":"2003","journal-title":"Pediatrics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ajhb.20121","article-title":"Age at natural menopause in Spain and the United States: results from the DAMES project","volume":"17","author":"Reynolds","year":"2005","journal-title":"Am J Hum Biol"},{"key":"B26","volume-title":"Key Statistics From the National Survey of Family Growth - S Listing","year":"2017"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/e414702008-001","article-title":"Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth","volume":"23","author":"Chandra","year":"2005","journal-title":"Vital Health Stat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0306-5456(00)00098-X","article-title":"Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales","volume":"108","author":"Redburn","year":"2001","journal-title":"BJOG"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Womens Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s10552-009-9395-y","article-title":"Hypothesis: neoplasms in myotonic dystrophy","volume":"20","author":"Mueller","year":"2009","journal-title":"Cancer Causes Control"},{"key":"B31","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1101\/gad.9.5.534","article-title":"The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation","volume":"9","author":"Justice","year":"1995","journal-title":"Genes Dev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1530\/ERC-12-0007","article-title":"miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5","volume":"19","author":"Chuang","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1210\/me.2008-0387","article-title":"MicroRNA-regulated pathways associated with endometriosis","volume":"23","author":"Ohlsson Teague","year":"2009","journal-title":"Mol Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/ijms18061207","article-title":"The functions of microRNA-200 family in ovarian cancer: beyond epithelial-mesenchymal transition","volume":"18","author":"Choi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2217\/epi.15.41","article-title":"The role of miRNAs in endometrial cancer","volume":"7","author":"Vasilatou","year":"2015","journal-title":"Epigenomics"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T04:38:35Z","timestamp":1570768715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":35,"alternative-id":["10.3389\/fneur.2019.01071"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01071","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"article-number":"1071"}}